CombiMatrix and Clarient Partner for Genomics-Based Test for Chronic Lymphotic Leukemia
CombiMatrix Corp, Mukilteo, Wash, and Clarient, Inc, Aliso Viejo, Calif, have partnered for HemeScan, a genomics-based cancer test for the treatment and care of chronic lymphocytic leukemia, and other cancers.
Read More